Skip to main content
Clinical Trials/KCT0008092
KCT0008092
Not yet recruiting
未知

A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer

Asan Medical Center0 sites334 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
334
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Women aged 20\-80 years
  • 2\) Untreated, histologically diagnosed cervical cancer, endometrial cancer, and ovarian cancer (including cases diagnosed by imaging without biopsy in the case of ovarian cancer)
  • 3\) Patients with ECOG performance status 0\-2
  • 4\) Patients with ASA PS 1\-2
  • 5\) Preoperative Hgb \= 7 g/dL
  • 6\) Patients who are scheduled for preoperative iron panel test (serum ferritin, iron, TIBC)
  • 7\) In case of showing proper organ function
  • WBC \= 3,000/mm3
  • Platelets \= 100,000/mm3
  • Creatinine \= 2\.0 mg/dL

Exclusion Criteria

  • 1\) Patient who unable to determine whether or not to consent on their own
  • 2\) Patients with serious underlying diseases or complications
  • 3\) Women who are pregnant or lactating
  • 4\) Patients with concurrent infection
  • 5\) Patients who are allergic to existing iron preparations
  • 6\) Patients who underwent neoadjuvant chemotherapy or preoperative radiation therapy
  • 7\) Patients who have had or received cancer treatment within 5 years, except for non\-melanoma skin cancer, cervical intraepithelial tumor, and superficial cancer of the stomach and bladder
  • 8\) Patients with iron overload or iron utilization disorders
  • 9\) Patients with serum ferritin \> 800ng/mL or TSAT \> 50% on Iron panel tests

Outcomes

Primary Outcomes

Not specified

Similar Trials